Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network

JD Rudzki; U Jaeger; D Wolf; A Petzer; Richard Greil; C Peters; HT Greinix; A Attarbaschi; V Buxhofer-Ausch; M Girschikofsky; W Holter; Michael Leisch; P Neumeister; P Schlenke; CA Schmitt; W Schwinger; N Worel; P Wohlfarth

doi:10.1182/blood-2022-167603

Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network

JD Rudzki, U Jaeger, D Wolf, A Petzer, Richard Greil, C Peters, HT Greinix, A Attarbaschi, V Buxhofer-Ausch, M Girschikofsky, W Holter, Michael Leisch, P Neumeister, P Schlenke, CA Schmitt, W Schwinger, N Worel, P Wohlfarth

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › published Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	6661-6663
Journal	BLOOD
Volume	140
DOIs	https://doi.org/10.1182/blood-2022-167603
Publication status	Published - 2022
Event	64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - New Orleans, LA Duration: 10 Dec 2022 → 13 Dec 2022

Access to Document

10.1182/blood-2022-167603

Cite this

Rudzki, JD., Jaeger, U., Wolf, D., Petzer, A., Greil, R., Peters, C., Greinix, HT., Attarbaschi, A., Buxhofer-Ausch, V., Girschikofsky, M., Holter, W., Leisch, M., Neumeister, P., Schlenke, P., Schmitt, CA., Schwinger, W., Worel, N., & Wohlfarth, P. (2022). Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network. BLOOD , 140, 6661-6663. https://doi.org/10.1182/blood-2022-167603

Rudzki, JD ; Jaeger, U ; Wolf, D et al. / Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network. In: BLOOD 2022 ; Vol. 140. pp. 6661-6663.

@article{dc5207619f054347a377770192d10cd3,

title = "Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network",

author = "JD Rudzki and U Jaeger and D Wolf and A Petzer and Richard Greil and C Peters and HT Greinix and A Attarbaschi and V Buxhofer-Ausch and M Girschikofsky and W Holter and Michael Leisch and P Neumeister and P Schlenke and CA Schmitt and W Schwinger and N Worel and P Wohlfarth",

year = "2022",

doi = "10.1182/blood-2022-167603",

language = "English",

volume = "140",

pages = "6661--6663",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

note = "64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) ; Conference date: 10-12-2022 Through 13-12-2022",

}

Rudzki, JD, Jaeger, U, Wolf, D, Petzer, A, Greil, R, Peters, C, Greinix, HT, Attarbaschi, A, Buxhofer-Ausch, V, Girschikofsky, M, Holter, W, Leisch, M, Neumeister, P, Schlenke, P, Schmitt, CA, Schwinger, W, Worel, N & Wohlfarth, P 2022, 'Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network', BLOOD , vol. 140, pp. 6661-6663. https://doi.org/10.1182/blood-2022-167603

Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network. / Rudzki, JD; Jaeger, U; Wolf, D et al.
In: BLOOD , Vol. 140, 2022, p. 6661-6663.

Research output: Contribution to journal › published Abstract (Journal) › peer-review

TY - JOUR

T1 - Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network

AU - Rudzki, JD

AU - Jaeger, U

AU - Wolf, D

AU - Petzer, A

AU - Greil, Richard

AU - Peters, C

AU - Greinix, HT

AU - Attarbaschi, A

AU - Buxhofer-Ausch, V

AU - Girschikofsky, M

AU - Holter, W

AU - Leisch, Michael

AU - Neumeister, P

AU - Schlenke, P

AU - Schmitt, CA

AU - Schwinger, W

AU - Worel, N

AU - Wohlfarth, P

PY - 2022

Y1 - 2022

U2 - 10.1182/blood-2022-167603

DO - 10.1182/blood-2022-167603

M3 - published Abstract (Journal)

SN - 0006-4971

VL - 140

SP - 6661

EP - 6663

JO - BLOOD

JF - BLOOD

T2 - 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)

Y2 - 10 December 2022 through 13 December 2022

ER -

Rudzki JD, Jaeger U, Wolf D, Petzer A, Greil R, Peters C et al. Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network. BLOOD . 2022;140:6661-6663. doi: 10.1182/blood-2022-167603